Ginkgo Bioworks Reports Second Quarter 2022 Financial Results
Go back to Ginkgo Bioworks Reports Second Quarter 2022 Financial Results| Genentech, Inc. (NYSE: DNA) | Delayed: 9.34 -0.77 (7.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.11 | 52 Week High | $99.14 | |||
| Open | $10.09 | 52 Week Low | $69.17 | |||
| Day High | $10.27 | P/E | 2.91 | |||
| Day Low | $9.16 | EPS | $3.21 | |||
| Volume | 1,161,859 | |||||

